← MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI
Market Price
$5.68
Market Cap
$2.14B
P/E Ratio
N/A
Revenue (FY 2025)
↓-28.3% YoY
$185.74M
3-Yr CAGR: -40.5%
Net Income
N/A
Net Margin: N/A
Free Cash Flow
↓-218.7% YoY
-$70.72M
FCF Yield: -3.30%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
N/A
ROA: N/A
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (MRVI)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2019 | $143.1M | — | $76.3M | — | — | — | — | $24.1M | $7.0M | — |
| FY 2020 | $284.1M | +98.5% | $204.4M | — | — | — | — | $152.2M | $126.8M | +1,719.7% |
| FY 2021 | $799.2M | +181.3% | $658.7M | — | — | — | — | $368.6M | $353.7M | +179.0% |
| FY 2022 | $883.0M | +10.5% | $714.0M | — | — | — | — | $536.0M | $518.9M | +46.7% |
| FY 2023 | $288.9M | -67.3% | $140.2M | — | — | — | — | $126.2M | $60.7M | -88.3% |
| FY 2024 | $259.2M | -10.3% | $108.3M | — | — | — | — | $7.5M | $-22.2M | -136.6% |
| FY 2025 | $185.7M | -28.3% | $34.0M | — | — | — | — | $-57.6M | $-70.7M | -218.7% |
Valuation
Market Price
$5.68
Market Cap
$2.14B
Enterprise Value
$2.22B
P/E Ratio
N/A
P/B Ratio
9.91
FCF Yield
-3.30%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
18.30%
Operating Margin
N/A
Net Margin
N/A
Return on Equity (ROE)
N/A
Return on Assets (ROA)
N/A
Asset Turnover
13.89x
Revenue 3-Yr CAGR
-40.53%
Financial Health & Liquidity
Current Ratio
0.37
Cash Ratio
5.93
Debt / Equity
1.374
Debt / Assets
21.826
Cash & Equivalents
$216.89M
Total Debt
$291.77M
Book Value / Share
$0.57
Cash Flow Efficiency
Operating Cash Flow
-$57.57M
Capital Expenditures (CapEx)
$13.15M
Free Cash Flow
-$70.72M
OCF / Revenue
-31.00%
FCF / Revenue
-38.08%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$0.57
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$13.37M
Total Liabilities
$36.57M
Stockholders' Equity
$212.38M
Current Assets
$13.37M
Current Liabilities
$36.57M